SCHEMBL9682260

SCHEMBL9682260

O=[N+]([O-])c1cc(Br)ccc1NCc1ccc(Cl)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.67
L3MBTL1 Q9Y468 2/20 0.67
TDP1 Q9NUW8 1/20 0.67
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
ALDH1A1 P00352 3/20 0.54
HTR6 P50406 2/20 0.50
NPSR1 Q6W5P4 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
HPGD P15428 1/20 0.47
CYP2C19 P33261 1/20 0.47
LMNA P02545 2/20 0.47
POLB P06746 2/20 0.47
RECQL P46063 1/20 0.47
BLM P54132 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
NPC1 O15118 1/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9682067 0.92 MAPT (0.76) MAPTL3MBTL1TDP1MEN1KMT2A
SCHEMBL9683242 0.88 MAPT (0.84) MAPTL3MBTL1TDP1MEN1KMT2A
SCHEMBL17149350 0.86 MAPT (0.71) MAPTL3MBTL1TDP1MEN1KMT2A
SCHEMBL594650 0.86 MAPT (0.61) MAPTL3MBTL1TDP1MEN1KMT2A
SCHEMBL9683008 0.83 MAPT (0.67) MAPTL3MBTL1TDP1MEN1KMT2A
SCHEMBL17152741 0.83 MAPT (0.50) MAPTL3MBTL1TDP1MEN1KMT2A
SCHEMBL9682931 0.81 MAPT (0.58) MAPTL3MBTL1TDP1MEN1KMT2A
SCHEMBL16043208 0.81 MAPT (0.53) MAPTL3MBTL1TDP1MEN1KMT2A
SCHEMBL7335661 0.80 MAPT (0.63) MAPTL3MBTL1TDP1MEN1KMT2A
SCHEMBL9682949 0.80 MAPT (0.67) MAPTL3MBTL1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5128359-A Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation LABORATOIRES UPSA (FR) 1992-07-07 US disclosed
US-5124336-A Cardiovascular disorders LABORATOIRES UPSA (FR) 1992-06-23 US disclosed